Cross-fund · 4 holders
EBS
EMERGENT BIOSOLUTIONS INC
CUSIP 29089Q105
4
Tracked holders
$85.4M
Aggregate value
8,555,662
Shares
4
Active funds
Funds holding EBS
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $43.9M | — | +13,329 | +0.4% |
| BlackRock | Institutional | Q1 2026 | $36.0M | — | +87,065 | +2.0% |
| Millennium | Multi-Strategy | Q1 2026 | $4.4M | — | +294,327 | +123.8% |
| Citadel | Multi-Strategy | Q1 2026 | $1.1M | — | −271,019 | −67.9% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.